Lippl F, Erdmann J, Lichter N, Tholl S, Wagenpfeil S, Adam O, Schusdziarra V
Division of Gastroenterology, Department of Internal Medicine, University Hospital of the Ludwig-Maximilians-University, Munich, Germany.
Horm Metab Res. 2008 Nov;40(11):806-12. doi: 10.1055/s-2008-1081503. Epub 2008 Jul 11.
Obestatin is supposed to be involved in nutrient homeostasis. Therefore, basal plasma obestatin levels were investigated in 321 normal weight and obese subjects in relation to body mass index, gender, age, insulin concentrations, and type 2 diabetes mellitus. Additionally, postprandial obestatin levels were determined in 20 normal weight subjects. Basal obestatin levels in females were higher compared to males (193.6+/-5.8 vs. 140.6+/-5.1 pg/ml). Obestatin levels correlated inversely and significantly with body mass index (f: r=-0.632, p<0.001; m: r=-0.487, p<0.001) and basal insulin levels (f: r=-0.536, p<0.001; m: r=-0.320, p=0.008) in females and males. However, in a multiple regression analysis as well as in a matched comparison of a low and high insulin group no significant relationship between insulin and obestatin levels was observed in nondiabetics. On the other hand, inclusion of type 2 diabetics with higher insulin levels resulted in a significant inverse correlation. Obestatin levels were independent of age in both sexes. In patients with type 2 diabetes mellitus basal obestatin levels were not different compared to nondiabetic subjects when matched for gender, body mass index, and insulin. In normal weight subjects, postprandial obestatin levels showed a significant decrease between 60 and 90 minutes rising to basal levels thereafter. The present data demonstrate a relation of plasma obestatin levels to body weight, gender and food intake, but not to age. The inverse relationship with insulin might depend on the level of hyperinsulinemia. The present data are compatible with a potential role of obestatin in nutrient regulation.
肥胖抑制素被认为参与营养稳态调节。因此,研究了321名正常体重和肥胖受试者的基础血浆肥胖抑制素水平与体重指数、性别、年龄、胰岛素浓度及2型糖尿病的关系。此外,还测定了20名正常体重受试者的餐后肥胖抑制素水平。女性的基础肥胖抑制素水平高于男性(193.6±5.8对140.6±5.1 pg/ml)。肥胖抑制素水平与体重指数呈显著负相关(女性:r = -0.632,p < 0.001;男性:r = -0.487,p < 0.001),与女性和男性的基础胰岛素水平也呈显著负相关(女性:r = -0.536,p < 0.001;男性:r = -0.320,p = 0.008)。然而,在多元回归分析以及低胰岛素组和高胰岛素组的配对比较中,未发现非糖尿病患者胰岛素与肥胖抑制素水平之间存在显著关系。另一方面,纳入胰岛素水平较高的2型糖尿病患者后,出现了显著的负相关。肥胖抑制素水平在两性中均与年龄无关。在2型糖尿病患者中,当按性别、体重指数和胰岛素进行匹配时,基础肥胖抑制素水平与非糖尿病受试者无差异。在正常体重受试者中,餐后肥胖抑制素水平在60至90分钟之间显著下降,此后升至基础水平。目前的数据表明血浆肥胖抑制素水平与体重、性别和食物摄入有关,但与年龄无关。与胰岛素的负相关可能取决于高胰岛素血症的水平。目前的数据与肥胖抑制素在营养调节中的潜在作用相符。